FDA Inspection 716411 — Shore Institute For Reproductive Medicine, P.C.

Shore Institute For Reproductive Medicine, P.C. — FEI 3003945094

The FDA completed an inspection of Shore Institute For Reproductive Medicine, P.C. on Mar 29, 2011 in Lakewood, NJ. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 1 citation was issued during this inspection. Product area: Biologics.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Mar 29, 2011
Fiscal Year
2011
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Lakewood, NJ (United States)

Citations

IDCFRDescription
1227721 CFR 1271.75(a)(1)Risk factors, clinical evidence

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.